Dexamethasone treatment increases neuropeptide Y levels in rat hypothalamic neurones. (Q48147219)

9 February 2018

title

Dexamethasone treatment increases neuropeptide Y levels in rat hypothalamic neurones. (English)

1 reference

9 February 2018

1 reference

Corder R

1

1 reference

9 February 2018

Pralong F

2

1 reference

9 February 2018

Turnill D

3

1 reference

9 February 2018

Saudan P

4

1 reference

9 February 2018

Muller AF

5

1 reference

9 February 2018

Gaillard RC

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 January 1988

1 reference

9 February 2018

published in

Life Sciences

1 reference

9 February 2018

volume

43

1 reference

9 February 2018

issue

23

1 reference

9 February 2018

page(s)

1879-1886

1 reference

9 February 2018

Neuropeptide Y Distribution in the Rat Brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system--I. Radioimmunoassay and chromatographic characterisation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

The anatomy of neuropeptide-Y-containing neurons in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Noradrenaline and neuropeptide Y innervation of the rat hypothalamus are differentially affected by 6-hydroxydopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Biochemistry, molecular biology, and physiology of the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

High molecular weight somatostatin secretion by cultured rat brain cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

An immunoradiometric assay for the measurement of neuropeptide Y in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Seven peptides derived from pro-somatostatin in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Assessment of corticotropin-releasing factor, vasopressin and somatostatin secretion by fetal hypothalamic neurons in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Ontogeny of a novel peptide, neuropeptide Y (NPY) in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Neuropeptide Y levels in microdissected regions of the hypothalamus and in vitro release in response to KCl and prostaglandin E2: effects of castration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Effect of dexamethasone on growth hormone (GH) response to growth hormone releasing hormone in acromegaly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Human pancreatic growth hormone releasing hormone fails to stimulate human growth hormone both in Cushing's disease and in Cushing's syndrome due to adrenocortical adenoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

Effect of human growth hormone-releasing hormone on GH secretion in Cushing's syndrome and non-endocrine disease patients treated with glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2888%2980005-5

10.1016/S0024-3205(88)80005-5

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

3200112

1 reference

9 February 2018